- Home
- CNTB vs RFAM Comparison
CNTB vs RFAM Comparison
Compare CNTB & RFAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CNTB | RFAM |
|---|---|---|
| Founded | 2012 | 2025 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 135.7M | 138.4M |
| IPO Year | 2020 | 2026 |
Fundamental Metrics
Financial Performance| Metric | CNTB | RFAM |
|---|---|---|
| Price | $2.21 | $9.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.67 | N/A |
| AVG Volume (30 Days) | ★ 677.5K | 6.4K |
| Earning Date | 08-13-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $64,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.23 | $9.77 |
| 52 Week High | $3.82 | $9.94 |
Technical Indicators
Market Signals| Indicator | CNTB | RFAM |
|---|---|---|
| Relative Strength Index (RSI) | 46.82 | 59.79 |
| Support Level | $2.14 | $9.77 |
| Resistance Level | $2.75 | $9.94 |
| Average True Range (ATR) | 0.23 | 0.00 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 10.87 | 75.13 |
Price Performance
Historical ComparisonAbout CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.
About RFAM RF Acquisition Corp III Ordinary Shares
RF Acquisition Corp III is a blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination.